Contact us for free information or to start a free case review.
A person may be able to seek Celebrex litigation if they have been injured as a result of taking Celebrex. Celebrex is a top selling COX-2 non-steroidal anti inflammatory drug (NSAID). The FDA approved Celebrex in 1999 to treat the pain associated with osteoarthritis, rheumatoid arthritis, menstrual cramps, and other chronic pain conditions. The prescription drug Celebrex is manufactured by Pfizer.
Celebrex litigation would be brought against Pfizer, the makers of this arguably defective drug, for failing to adequately inform and protect consumers about serious potential risks associated with Celebrex use. Celebrex litigation is pursued through the criminal court system. Through Celebrex litigation, the victim of Celebrex injuries, the plaintiff, can seek restitution for their losses.
There are two ways that Celebrex litigation can be brought to the civil court system. A person can file an individual lawsuit, through which they will be the only party seeking compensation for their Celebrex losses. A Celebrex class action lawsuit is another way that Celebrex litigation can be pursued. In a class action lawsuit, multiple parties will be named as plaintiffs, all of which are seeking compensation for damages related to Celebrex. The monetary amount that is awarded in class action Celebrex litigation is divided between the parties represented in the lawsuit.
Celebrex litigation can facilitate the reparation of a person’s Celebrex damages including related medical expenses, loss of income or earning potential, disability, and psychological suffering. In a case of wrongful death caused by Celebrex side effects, the beneficiaries and dependents of the decedent may also be eligible to seek compensation for Celebrex damages.
It is important to keep in mind that any type of Celebrex litigation is subject to a state-specific statute of limitations. A statute of limitations restricts the amount of time a person has to file a Celebrex personal injury lawsuit. The time of a statute of limitations typically begins when the victim learns that his/her losses were caused by Celebrex use and ends when that party enters Celebrex litigation.
Celebrex litigation is already underway across the United States. Celebrex is the last of the top selling COX-2 NSAIDs that has not been recalled from the market because of deadly side effects. Both Vioxx (Merck) in September 2004 and Bextra (Pfizer) in April 2005, respectively, were pulled from the market because they increase the risk of serious adverse cardiovascular events such as heart attack and stroke. Celebrex has also been associated with these risks, though Pfizer has still allowed this potentially dangerous drug to remain on the market. In conjunction with the Bextra recall, the FDA ordered Pfizer to strengthen the warnings about cardiovascular risks on all Celebrex information. Some experts believe that a Celebrex recall is inevitable, and will trigger an even greater number of Celebrex litigation cases. Recall or not, Celebrex has still been shown to cause cardiovascular problems. Any party who has suffered Celebrex damages may wish to explore their rights and options with regards to Celebrex litigation.
After COX-2 painkillers – Vioxx, Celebrex and Bextra- came under scrutiny when cardiovascular risks were associated to the drugs some drugmakers saw this as an opportunity to try to capitalize on the events.
Vioxx went off the market in Se...
Merck & Co. and Pfizer Inc. have been criticized for their aggressive marketing campaigns for its COX-2 drugs, putting scrutiny on pharmaceutical advertising as a whole. Between December 2003 and November 2004, pharmaceutical ad spending increased 30...
A three-day FDA Advisory Committee meeting has wrapped, but the COX-2 drugs controversy is still not resolved. Although the panel of government medical experts advised keeping the drugs, including Pfizer Inc.’s Celebrex and Bextra, on the market, new...
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.